Please enable JavaScript to continue using this application.

Compare $ANIK vs $BBOT | Chartloom

Compare

$ANIK vs $BBOT

Anika Therapeutics Inc · BridgeBio Oncology Therapeutics Inc

ANIK

Anika Therapeutics Inc

BBOT

BridgeBio Oncology Therapeutics Inc

Compare $ANIK vs $BBOT

Comparing Anika Therapeutics Inc and BridgeBio Oncology Therapeutics Inc

ANIKAnika Therapeutics Inc

BBOTBridgeBio Oncology Therapeutics Inc

ANIKAnika Therapeutics Inc

Market cap

$262M

P/E (TTM)

—

Forward P/E (NTM)

57.30x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

-2.5%

YTD performance

109.4%

52W performance

111.9%

FCF yield

0.2%

BBOTBridgeBio Oncology Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.1%

52W performance

-72.5%

FCF yield

-73.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIK

BBOT

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

BBOT

BridgeBio Oncology Therapeutics Inc

Market Cap

ANIK$262M

BBOT$265M

Enterprise Value

ANIK$224M

BBOT$211M

Price

ANIK$19.58

BBOT$3.31

P/E Ratio

ANIKN/A

BBOTN/A

P/S Ratio

ANIK2.17x

BBOT0.00x

EV/Sales

ANIK1.85x

BBOT0.00x

EV/EBITDA

ANIK84.97x

BBOT0.00x

P/B Ratio

ANIK1.86x

BBOT0.97x

P/FCF Ratio

ANIK466.16x

BBOTN/A

EV/FCF

ANIK397.81x

BBOT-1.09x

PEG Ratio

ANIKN/A

BBOTN/A

Forward P/E (NTM)

ANIK57.30x

BBOTN/A

Forward P/S (NTM)

ANIK2.09x

BBOTN/A

Revenue (TTM)

ANIK$121M

BBOT$0

Revenue Growth (YoY)

ANIK-2.5%

BBOTN/A

Forward Rev Growth

ANIK5.2%

BBOT540.3%

Gross Margin (TTM)

ANIK62.2%

BBOT0.0%

Operating Margin (TTM)

ANIK0.0%

BBOT0.0%

EBITDA Margin (TTM)

ANIK2.2%

BBOT0.0%

Net Margin (TTM)

ANIK-3.1%

BBOT0.0%

FCF Margin (TTM)

ANIK0.5%

BBOTN/A

Net Income (TTM)

ANIK$-4M

BBOT$-182M

FCF (TTM)

ANIK$562K

BBOT$-194M

EPS (TTM)

ANIK-$0.28

BBOT-$2.27

ROE (TTM)

ANIK-270.0%

BBOT-4690.0%

ROA (TTM)

ANIK-204.0%

BBOT-4217.0%

ROIC (TTM)

ANIK-270.0%

BBOT-4690.0%

Cash

ANIK$38M

BBOT$54M

Debt

ANIK$0

BBOT$0

Net Cash/Debt

ANIK$38M

BBOT$54M

Current Ratio (TTM)

ANIK4.48x

BBOT4.69x

Quick Ratio (TTM)

ANIK3.05x

BBOT4.38x

Debt/Equity (TTM)

ANIK0.00x

BBOT0.00x

Debt/Assets (TTM)

ANIK0.0%

BBOT0.0%

Interest Coverage (TTM)

ANIKN/A

BBOTN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

BBOT0.00x

Beta

ANIK0.23

BBOT0.67

52W Performance

ANIK111.9%

BBOT-72.5%

YTD Performance

ANIK109.4%

BBOT-73.1%

% from 52W High

ANIK-14.4%

BBOT-77.7%

% from 52W Low

ANIK125.8%

BBOT1.2%

Asset Turnover (TTM)

ANIK0.65x

BBOT0.00x

FCF Yield (TTM)

ANIK0.2%

BBOT-73.1%

Earnings Yield (TTM)

ANIK-1.4%

BBOT-68.7%

Dividend Yield (TTM)

ANIKN/A

BBOTN/A

Rule of 40

ANIK-2.0

BBOT0.0

EV/GP/RG

ANIK0.81

BBOTN/A

Ticker research

View ANIK research View BBOT research

Metric	ANIK Anika Therapeutics Inc	BBOT BridgeBio Oncology Therapeutics Inc
Market & Valuation
Market Cap	$262M	$265M
Enterprise Value	$224M	$211M
Price	$19.58	$3.31
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	0.00x
EV/Sales	1.85x	0.00x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	0.97x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	N/A
Revenue & Growth
Revenue (TTM)	$121M	$0
Revenue Growth (YoY)	-2.5%	N/A
Forward Rev Growth	5.2%	540.3%
Profitability
Gross Margin (TTM)	62.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	0.0%
Net Margin (TTM)	-3.1%	0.0%
FCF Margin (TTM)	0.5%	N/A
Net Income (TTM)	$-4M	$-182M
FCF (TTM)	$562K	$-194M
EPS (TTM)	-$0.28	-$2.27
ROE (TTM)	-270.0%	-4690.0%
ROA (TTM)	-204.0%	-4217.0%
ROIC (TTM)	-270.0%	-4690.0%
Financial Health
Cash	$38M	$54M
Debt	$0	$0
Net Cash/Debt	$38M	$54M
Current Ratio (TTM)	4.48x	4.69x
Quick Ratio (TTM)	3.05x	4.38x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.67
52W Performance	111.9%	-72.5%
YTD Performance	109.4%	-73.1%
% from 52W High	-14.4%	-77.7%
% from 52W Low	125.8%	1.2%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.00x
FCF Yield (TTM)	0.2%	-73.1%
Earnings Yield (TTM)	-1.4%	-68.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	0.0
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View BBOT research

Valuation

P/S Ratio

BBOT

0.00x

ANIK

2.17x

EV/FCF

BBOT

-1.09x

ANIK

397.81x

Growth & revenue

Revenue Growth TTM

ANIK

-2.5%

Forward Revenue Growth

BBOT

540.3%

ANIK

5.2%

Profitability & performance

Gross Margin

ANIK

62.2%

BBOT

0.0%

ROE

ANIK

-270.0%

BBOT

-4690.0%

FCF Yield %

ANIK

0.2%

BBOT

-73.1%

52-Week Performance

ANIK

111.9%

BBOT

-72.5%

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

BBOT

BridgeBio Oncology Therapeutics Inc

Market Cap

ANIK$262M

BBOT$265M

Enterprise Value

ANIK$224M

BBOT$211M

Price

ANIK$19.58

BBOT$3.31

P/E Ratio

ANIKN/A

BBOTN/A

P/S Ratio

ANIK2.17x

BBOT0.00x

EV/Sales

ANIK1.85x

BBOT0.00x

EV/EBITDA

ANIK84.97x

BBOT0.00x

P/B Ratio

ANIK1.86x

BBOT0.97x

P/FCF Ratio

ANIK466.16x

BBOTN/A

EV/FCF

ANIK397.81x

BBOT-1.09x

PEG Ratio

ANIKN/A

BBOTN/A

Forward P/E (NTM)

ANIK57.30x

BBOTN/A

Forward P/S (NTM)

ANIK2.09x

BBOTN/A

Revenue (TTM)

ANIK$121M

BBOT$0

Revenue Growth (YoY)

ANIK-2.5%

BBOTN/A

Forward Rev Growth

ANIK5.2%

BBOT540.3%

Gross Margin (TTM)

ANIK62.2%

BBOT0.0%

Operating Margin (TTM)

ANIK0.0%

BBOT0.0%

EBITDA Margin (TTM)

ANIK2.2%

BBOT0.0%

Net Margin (TTM)

ANIK-3.1%

BBOT0.0%

FCF Margin (TTM)

ANIK0.5%

BBOTN/A

Net Income (TTM)

ANIK$-4M

BBOT$-182M

FCF (TTM)

ANIK$562K

BBOT$-194M

EPS (TTM)

ANIK-$0.28

BBOT-$2.27

ROE (TTM)

ANIK-270.0%

BBOT-4690.0%

ROA (TTM)

ANIK-204.0%

BBOT-4217.0%

ROIC (TTM)

ANIK-270.0%

BBOT-4690.0%

Cash

ANIK$38M

BBOT$54M

Debt

ANIK$0

BBOT$0

Net Cash/Debt

ANIK$38M

BBOT$54M

Current Ratio (TTM)

ANIK4.48x

BBOT4.69x

Quick Ratio (TTM)

ANIK3.05x

BBOT4.38x

Debt/Equity (TTM)

ANIK0.00x

BBOT0.00x

Debt/Assets (TTM)

ANIK0.0%

BBOT0.0%

Interest Coverage (TTM)

ANIKN/A

BBOTN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

BBOT0.00x

Beta

ANIK0.23

BBOT0.67

52W Performance

ANIK111.9%

BBOT-72.5%

YTD Performance

ANIK109.4%

BBOT-73.1%

% from 52W High

ANIK-14.4%

BBOT-77.7%

% from 52W Low

ANIK125.8%

BBOT1.2%

Asset Turnover (TTM)

ANIK0.65x

BBOT0.00x

FCF Yield (TTM)

ANIK0.2%

BBOT-73.1%

Earnings Yield (TTM)

ANIK-1.4%

BBOT-68.7%

Dividend Yield (TTM)

ANIKN/A

BBOTN/A

Rule of 40

ANIK-2.0

BBOT0.0

EV/GP/RG

ANIK0.81

BBOTN/A

Ticker research

View ANIK research View BBOT research

Metric	ANIK Anika Therapeutics Inc	BBOT BridgeBio Oncology Therapeutics Inc
Market & Valuation
Market Cap	$262M	$265M
Enterprise Value	$224M	$211M
Price	$19.58	$3.31
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	0.00x
EV/Sales	1.85x	0.00x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	0.97x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	N/A
Revenue & Growth
Revenue (TTM)	$121M	$0
Revenue Growth (YoY)	-2.5%	N/A
Forward Rev Growth	5.2%	540.3%
Profitability
Gross Margin (TTM)	62.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	0.0%
Net Margin (TTM)	-3.1%	0.0%
FCF Margin (TTM)	0.5%	N/A
Net Income (TTM)	$-4M	$-182M
FCF (TTM)	$562K	$-194M
EPS (TTM)	-$0.28	-$2.27
ROE (TTM)	-270.0%	-4690.0%
ROA (TTM)	-204.0%	-4217.0%
ROIC (TTM)	-270.0%	-4690.0%
Financial Health
Cash	$38M	$54M
Debt	$0	$0
Net Cash/Debt	$38M	$54M
Current Ratio (TTM)	4.48x	4.69x
Quick Ratio (TTM)	3.05x	4.38x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.67
52W Performance	111.9%	-72.5%
YTD Performance	109.4%	-73.1%
% from 52W High	-14.4%	-77.7%
% from 52W Low	125.8%	1.2%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.00x
FCF Yield (TTM)	0.2%	-73.1%
Earnings Yield (TTM)	-1.4%	-68.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	0.0
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View BBOT research